Literature DB >> 10529029

A comparison of C/B ratios from studies using receiver operating characteristic curve analysis.

S B Cantor1, C C Sun, G Tortolero-Luna, R Richards-Kortum, M Follen.   

Abstract

In receiver operating characteristic (ROC) curve analysis, the optimal cutoff value for a diagnostic test can be found on the ROC curve where the slope of the curve is equal to (C/B) x (1-p[D])/p[D], where p[D] is the disease prevalence and C/B is the ratio of net costs of treating nondiseased individuals to net benefits of treating diseased individuals. We conducted a structured review of the medical literature to examine C/B ratios found in ROC curve analysis. Only two studies were found in which a C/B ratio was explicitly calculated; in another 11 studies, a C/B ratio was based on a so-called holistic estimate, an all-encompassing educated estimate of the relative costs and benefits relevant to the clinical situation. The C/B ratios ranged from 0.0025 (tuberculosis screening) to 2.7 (teeth restoration for carious lesions). Clinical scenarios that are directly life threatening but curable had C/B ratios of less than 0.05. This analysis led us to construct a table of ordered C/B ratios that may be used by investigators to approximate C/B ratios for other clinical situations in order to establish cutpoints for new diagnostic tests.

Entities:  

Mesh:

Year:  1999        PMID: 10529029     DOI: 10.1016/s0895-4356(99)00075-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  40 in total

1.  Developing a utility decision framework to evaluate predictive models in breast cancer risk estimation.

Authors:  Yirong Wu; Craig K Abbey; Xianqiao Chen; Jie Liu; David C Page; Oguzhan Alagoz; Peggy Peissig; Adedayo A Onitilo; Elizabeth S Burnside
Journal:  J Med Imaging (Bellingham)       Date:  2015-08-17

2.  Comparing costs associated with risk stratification rules for t-year survival.

Authors:  Tianxi Cai; Lu Tian; Donald M Lloyd-Jones
Journal:  Biostatistics       Date:  2011-03-16       Impact factor: 5.899

3.  Unique genetic variation at a species' rear edge is under threat from global climate change.

Authors:  Jim Provan; Christine A Maggs
Journal:  Proc Biol Sci       Date:  2011-05-18       Impact factor: 5.349

4.  Optical technologies and molecular imaging for cervical neoplasia: a program project update.

Authors:  Timon P H Buys; Scott B Cantor; Martial Guillaud; Karen Adler-Storthz; Dennis D Cox; Clement Okolo; Oyedunni Arulogon; Oladimeji Oladepo; Karen Basen-Engquist; Eileen Shinn; José-Miguel Yamal; J Robert Beck; Michael E Scheurer; Dirk van Niekerk; Anais Malpica; Jasenka Matisic; Gregg Staerkel; Edward Neely Atkinson; Luc Bidaut; Pierre Lane; J Lou Benedet; Dianne Miller; Tom Ehlen; Roderick Price; Isaac F Adewole; Calum MacAulay; Michele Follen
Journal:  Gend Med       Date:  2011-09-22

5.  Feeding habitat quality and behavioral trade-offs in chimpanzees: a case for species distribution models.

Authors:  Steffen Foerster; Ying Zhong; Lilian Pintea; Carson M Murray; Michael L Wilson; Deus C Mjungu; Anne E Pusey
Journal:  Behav Ecol       Date:  2016-01-31       Impact factor: 2.671

6.  Physician attitudes toward dissemination of optical spectroscopy devices for cervical cancer control: an industrial-academic collaborative study.

Authors:  Eileen Shinn; Usman Qazi; Shalini Gera; Joan Brodovsky; Jessica Simpson; Michele Follen; Karen Basen-Engquist; Calum Macaulay
Journal:  Gend Med       Date:  2012-02

7.  Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes.

Authors:  Wei Yu; Tiebin Liu; Rodolfo Valdez; Marta Gwinn; Muin J Khoury
Journal:  BMC Med Inform Decis Mak       Date:  2010-03-22       Impact factor: 2.796

8.  Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients.

Authors:  Pritika C Kumar; Charles M Cleland; Marc N Gourevitch; John Rotrosen; Shiela Strauss; Linnea Russell; Jennifer McNeely
Journal:  Drug Alcohol Depend       Date:  2016-06-22       Impact factor: 4.492

9.  The utility of screening in the design of trials for symptom management in cancer.

Authors:  Sangchoon Jeon; Charles W Given; Alla Sikorskii; Barbara Given
Journal:  J Pain Symptom Manage       Date:  2009-08-20       Impact factor: 3.612

10.  Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis.

Authors:  I Corral; C Quereda; E Navas; P Martín-Dávila; M-J Pérez-Elías; J-L Casado; V Pintado; J Cobo; E Pallarés; J Rubí; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-13       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.